APA (7th ed.) Citation

Z, Y., L, L., D, F., W, W., N, Q., Y, H., . . . W, Z. (2023). Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy. Frontiers of medicine, 17(4), 699. https://doi.org/10.1007/s11684-022-0972-8

Chicago Style (17th ed.) Citation

Z, Yan, et al. "Immunosuppressive Tumor Microenvironment Contributes to Tumor Progression in Diffuse Large B-cell Lymphoma upon Anti-CD19 Chimeric Antigen Receptor T Therapy." Frontiers of Medicine 17, no. 4 (2023): 699. https://doi.org/10.1007/s11684-022-0972-8.

MLA (9th ed.) Citation

Z, Yan, et al. "Immunosuppressive Tumor Microenvironment Contributes to Tumor Progression in Diffuse Large B-cell Lymphoma upon Anti-CD19 Chimeric Antigen Receptor T Therapy." Frontiers of Medicine, vol. 17, no. 4, 2023, p. 699, https://doi.org/10.1007/s11684-022-0972-8.